General Information of Drug Off-Target (DOT) (ID: OTMDWHOM)

DOT Name 3-oxoacyl- synthase, mitochondrial (OXSM)
Synonyms EC 2.3.1.41; Beta-ketoacyl-ACP synthase
Gene Name OXSM
UniProt ID
OXSM_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2C9H; 2IWY; 2IWZ
EC Number
2.3.1.41
Pfam ID
PF00109 ; PF02801
Sequence
MSNCLQNFLKITSTRLLCSRLCQQLRSKRKFFGTVPISRLHRRVVITGIGLVTPLGVGTH
LVWDRLIGGESGIVSLVGEEYKSIPCSVAAYVPRGSDEGQFNEQNFVSKSDIKSMSSPTI
MAIGAAELAMKDSGWHPQSEADQVATGVAIGMGMIPLEVVSETALNFQTKGYNKVSPFFV
PKILVNMAAGQVSIRYKLKGPNHAVSTACTTGAHAVGDSFRFIAHGDADVMVAGGTDSCI
SPLSLAGFSRARALSTNSDPKLACRPFHPKRDGFVMGEGAAVLVLEEYEHAVQRRARIYA
EVLGYGLSGDAGHITAPDPEGEGALRCMAAALKDAGVQPEEISYINAHATSTPLGDAAEN
KAIKHLFKDHAYALAVSSTKGATGHLLGAAGAVEAAFTTLACYYQKLPPTLNLDCSEPEF
DLNYVPLKAQEWKTEKRFIGLTNSFGFGGTNATLCIAGL
Function May play a role in the biosynthesis of lipoic acid as well as longer chain fatty acids required for optimal mitochondrial function.
Tissue Specificity Widely expressed. Higher expression in heart, skeletal muscle, liver and kidney which contain high levels of active mitochondria.
KEGG Pathway
Fatty acid biosynthesis (hsa00061 )
Biotin metabolism (hsa00780 )
Metabolic pathways (hsa01100 )
Fatty acid metabolism (hsa01212 )
Biosynthesis of cofactors (hsa01240 )
BioCyc Pathway
MetaCyc:HS07707-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of 3-oxoacyl- synthase, mitochondrial (OXSM). [1]
------------------------------------------------------------------------------------
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [2]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [3]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [4]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [5]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [6]
Cidofovir DMA13GD Approved Cidofovir increases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [5]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [7]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [8]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [9]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [10]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of 3-oxoacyl- synthase, mitochondrial (OXSM). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
2 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
3 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
4 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
5 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
6 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
9 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
10 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.
11 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.